Product Datasheet  
Granzyme B Antibody  
Catalog Number: 48298  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species:  
  • Mouse
  • Amount:  
  • 100μgμg
  • Swiss-Prot No.:  
  • Swiss-Prot#:P10144
  • Form of Antibody:  
  • 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
  • Storage:  
  • Store at -20˚C
  • Immunogen:  
  • Amino acids 1-247 representing full length granzyme B of human origin.
  • reactivity:  
  • Hu, Ms, Rt
  • appl_detail:  
  • WB: 1:100-1:1,000
    IHC: 1:50-500

    IP: 1-2 μg per 100-500 μg of total protein(1 ml of cell lysate)
  • other_names:  
  • C11 antibody
    Cathepsin G like 1 antibody
    Cathepsin G-like 1 antibody
    CCPI antibody
    CGL 1 antibody
    CGL1 antibody
    CSP B antibody
    CSPB antibody
    CTLA-1 antibody
    CTLA1 antibody
    CTSGL1 antibody
    Cytotoxic serine protease B antibody
    Cytotoxic T lymphocyte associated serine esterase 1 antibody
    Cytotoxic T lymphocyte proteinase 2 antibody
    Cytotoxic T-lymphocyte proteinase 2 antibody
    Fragmentin 2 antibody
    Fragmentin-2 antibody
    GRAB_HUMAN antibody
    Granzyme 2 antibody
    Granzyme B (granzyme 2, cytotoxic T lymphocyte associated serine esterase 1) antibody
    Granzyme B antibody
    Granzyme-2 antibody
    GranzymeB antibody
    GRB antibody
    Gzmb antibody
    Hlp antibody
    Human lymphocyte protein antibody
    Lymphocyte protease antibody
    Protease, serine, B antibody
    SECT antibody
    T cell serine protease 1-3E antibody
    T-cell serine protease 1-3E antibody
  • Purification:  
  • ProA affinity purified
  • Specificity:  
  • Applications:  
  • WB, IP, IF, IHC(P)
  • Background:  
  • Granzyme A and granzyme B are serine proteases that mediate apoptotic signaling in cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Both granzyme A and granzyme B are synthesized as inactive proenzymes, and they are stored within cytolytic granules and released by effector cells during degranulation. In activated CTLs, granzyme A and granzyme B are processed and activated by cathepsin C, and they then function to induce apoptosis by two distinct pathways. Granzyme B proteolytically cleaves and activates members of the caspase family of cysteine proteases, including caspase-3, caspase-6, caspase-7 and caspase-9. When cleaved, these caspases assemble into active holoenzymes that then mediate apoptosis through a defined proteolytic cascade involving nuclear lamins and PARP (poly ADP ribose polymerase). Granzyme A mediates the activation of apoptosis by inducing single-strand DNA breaks, membrane perturbation and nuclear condensations in an alternative pathway that is independent from caspase activation or the caspase proteolytic cascade.



 
© Signalway Biotechnology All Rights Reserved.